STOCK TITAN

[SCHEDULE 13G/A] iBio, Inc. Amended Passive Investment Disclosure

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

iBio, Inc. received an amended Schedule 13G/A from Lynx1 Capital Management LP and Weston Nichols stating they no longer beneficially own any of the company’s common stock. The filing reports 0 shares beneficially owned and a 0% ownership stake, with no voting or dispositive power over any shares.

The reporting persons also certify that the securities referenced were not acquired and are not held for the purpose of changing or influencing control of iBio, Inc., and are not part of any control-related transaction.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Lynx1 Capital Management LP
Signature:/s/ Weston Nichols
Name/Title:Lynx1 Capital Management GP LLC, General Partner, By: Weston Nichols, Sole Member
Date:02/17/2026
Weston Nichols
Signature:/s/ Weston Nichols
Name/Title:Weston Nichols, Individually
Date:02/17/2026
Ibio

NASDAQ:IBIO

IBIO Rankings

IBIO Latest News

IBIO Latest SEC Filings

IBIO Stock Data

76.69M
26.86M
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW YORK